Chonnam Med J.  2004 Sep;40(3):142-147.

Vitrectomy of Non-diabetic and Non-traumatic Vitreous Hemorrhage

Affiliations
  • 1Department of Ophthalmology, Chonnam National University Medical School, Korea. msseo@chonnam.ac.kr
  • 2Chonnam National University Research Institute of Medical Sciences, Gwangju, Korea.

Abstract

To determine the cause and long-term visual prognosis of severe non-diabetic and non-traumatic vitreous hemorrhage, we reviewed the patients who had undergone a vitrectomy for the treatment of severe non-diabetic and non-traumatic vitreous hemorrhage and were followed-up over 12 months. Of all 51 eyes, 50 patients, male was 23 patients and mean age was 60.2 years. The causes of vitreous hemorrhage were branch retinal vein occlusion (BRVO) in 33 eyes (64.7%), Terson syndrome in 5 eyes (9.8%), age-related macular degeneration in 4 eyes (7.8%), central retinal vein occlusion (CRVO) and hemi-CRVO and Eales' disease in 2 eyes (3.9%), respectively, and horseshoe retinal tear, arterial macroaneurysm and the unknown in 1 eye (2.0%), respectively. Mean duration of vitreous hemorrhage was 10.2 months and follow-up period was 19.4 months. On the final visit, visual acuity was 0.5 or more in 24 eyes (47.1%) and 0.04 or more in 41 eyes (80.4%), and improved 5 lines or more in 38 eyes (74.5%) and 2 lines or more in 45 eyes (88.2%). BRVO is the main cause of severe non-diabetic and non-traumatic vitreous hemorrhage. Long-term visual prognosis of vitrectomy was quite good in general, but poor in cases of severe macular involvement.

Keyword

Non-diabetic; Non-traumatic; Pars plana vitrectomy; Vitreous hemorrhage

MeSH Terms

Follow-Up Studies
Humans
Macular Degeneration
Male
Prognosis
Retinal Perforations
Retinal Vein
Retinal Vein Occlusion
Visual Acuity
Vitrectomy*
Vitreous Hemorrhage*
Full Text Links
  • CMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error